Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
The time has come for biotech companies to embrace machine learning for clinical trials, but they should start with compiling the data. That means grappling with real-world patient records.
As cultivated meat begins to enter grocery stores, governments should promote the field’s development in line with broad public goals of sustainability and accessibility.
Decentralized autonomous organizations are growing as alternative research funding models, but are also strong scientific communities. We should get on board.